• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Takeda eyes vaccine business growth as dengue, COVID-19 shots progress – CEO

September 14, 2021 by David Barret Leave a Comment

September 14, 2021

By Rocky Swift

TOKYO (Reuters) – Takeda Pharmaceutical Co, which distributes Moderna Inc’s COVID-19 shots in Japan, expects vaccines to become a bigger part of its portfolio as shots for dengue fever and COVID-19 near regulatory approval, its chief executive said.

Takeda, Japan’s biggest drugmaker and among the top 10 globally after its 2019 takeover of Shire Plc, has traditionally been known more for its cancer and gastrointestinal treatments.

But vaccines have defined much of the company’s activities during the coronavirus pandemic, as it worked to bring foreign-developed shots into Japan.

Vaccine production is a business that “when established, has a very long life,” Takeda CEO Christophe Weber said in an interview broadcast at Reuters Events’ Pharma Japan 2021 conference on Tuesday.

“There is no generic of vaccines, for example. So it’s a different type of lifecycle, but it can be a very good business if you bring innovation,” he added.

Takeda’s dengue fever vaccine was submitted to European regulators in March, and the company said it planned to file for approval in several South American and Asian countries this year. Takeda has been working for almost 10 years on the shot, which is now in the “last stage,” Weber said.

The company has imported some 50 million doses of Moderna’s COVID-19 vaccine into Japan and has a license to manufacture Novavax Inc’s vaccine, which is still undergoing trials.

Japan’s government has agreed to buy another 50 million Moderna shots, to be delivered next year, along with 150 million Novavax doses.

About 1.6 million Moderna doses were recalled in Japan this month after the discovery of small metal contaminants in some vials, a problem traced back to a production line in Spain.

Weber said such problems sometimes occur in pharma manufacturing, brushing off the suggestion it was caused by companies rushing to bring vaccines to market.

With some of its main sellers due to lose patent protection in the coming years, Takeda is betting heavily on a pipeline of more than 10 drugs in late-stage development. One of those, a blood cancer treatment known as Pevonedistat, fell out of the running this month after poor trial results.

“We don’t rely on one product in our pipeline, or two, when we have 40 in clinical stage,” Weber said.

(Reporting by Rocky Swift; Editing by Sam Holmes)

Source Link Takeda eyes vaccine business growth as dengue, COVID-19 shots progress – CEO

David Barret
David Barret

Related posts:

  1. India’s economic growth will remain strong in coming quarters, S&P says
  2. Shareholders may pursue 737 MAX claims against Boeing board, court rules
  3. Real-time database platform SingleStore raises $80M more, now at a $940M valuation
  4. Abu Dhabi expected to raise $3 billion via bonds

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • DNA From Greenland Sled Dogs – Maybe The World’s Oldest Breed – Reveals 1,000 Years Of Arctic History
  • Why Doesn’t Moonrise Shift By The Same Amount Each Night?
  • Moa De-Extinction, Fashionable Chimps, And Robot Surgery – No Human Required
  • “Human”: Powerful New Images Mark The Most Scientifically Accurate “Hyper-Real 3D Models Of Human Species Ever”
  • Did We Accidentally Leave Life On The Moon In 2019 – And Could We Revive It?
  • 1.8 Million Years Ago, Two Extinct Humans Had One Of The Gnarliest Deaths In History
  • “Powerful Image” Of One Of The World’s Rarest Tigers Exposes The Real Danger In Taman Negara
  • Evolution, Domestication, And A Lot Of Very Good Boys: How Wolves Became Dogs
  • Why Do Orcas Have White Spots Near Their Eyes?
  • Tomb Of First King Of Ancient Maya City Discovered In Belize
  • The Real Reason The Tip Of Your Tape Measure Wiggles Like That
  • The “Haunting” Last Message From NASA’s Opportunity Rover, Sent From Inside A Planet-Wide Storm
  • Adorable Video Proves Not All Gorillas Hate The Rain. It Might Even Win One A Mate
  • 5,000-Year-Old Rock Art May Show One Of Ancient Egypt’s First Rulers
  • Alzheimer’s-Linked Protein Levels “20 Times Higher” In Newborn Babies – What Does This Mean?
  • Americans Were Asked If They Thought Civil War Was Coming. The Results Were Unexpected
  • Voyager 1 & 2 Could Be Detected From Almost A Light-Year Away With Our Current Technology
  • Dams Have Nudged Earth’s Poles By Over 1 Meter In The Past 200 Years
  • This Sugar Could Be A Cure For Male Pattern Baldness – And It’s Been In Our Bodies All Along
  • “Cosmic Immigrants”: Daytime Star Seen In 1604 May Be An “Alien Type Ia Supernova”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version